| CS | calf serum; campomelic syndrome; carcinoid syndrome; cardiogenic shock; caries-susceptible; carotid ... |
|---|---|
| ARSC | arylsulfatase C; Associate of the Royal Society of Chemistry |
| chem | chemistry, chemical; chemotherapy |
| CSCV | critical serum chemistry value |
| CSP | carotid sinus pressure; cavum septi pellucidi; cell surface protein; cerebrospinal protein; Chartere... |
| chemistry, inorganic | A field of chemistry which pertains to chemical compounds or ions that do not contain the element carbon (with the exception of carbon dioxide and compounds containing a carbonate radical, e.g., calcium carbonate). (12 Dec 1998) |
|---|---|
| chemistry, pharmaceutical | Chemistry that deals with the composition and preparation of substances used in treatment of patients or diagnostic studies. (12 Dec 1998) |
| pharmaceutical chemistry | Medicinal chemistry in its application to the analysis, development, preparation, and the manufacture of drugs. Synonym: medicinal chemistry, pharmacochemistry. (05 Mar 2000) |
| physiological chemistry | The scientific study of the chemistry of living cells, tissues, organs and organisms. (09 Oct 1997) |
| computational chemistry | <chemistry> The use of computers to aid in the analysis of chemicals. (05 Jan 1998) |
| nuclear chemistry | The science concerned with the chemistry of nuclear reactions and processes. (05 Mar 2000) |
| synthetic chemistry | The formation or building up of complex compounds by uniting the more simple ones. (05 Mar 2000) |
| inorganic chemistry | The science concerned with compounds not involving carbon-containing molecules. (05 Mar 2000) |
| organic chemistry | <chemistry> A branch of chemistry that deals specifically with the structures, synthesis and reactions of carbon-containing compounds. (11 Jan 1998) |
| ecological chemistry | Chemistry that concentrates on the effects of woman-made chemicals on the environment as well as the development of agents that are not harmful to the environment. The study of the molecular interactions between species and between species and the environment. (05 Mar 2000) |
| epithermal chemistry | So-called "hot atom" chemistry; the science concerned with the chemical reactions of recoil atoms and free radicals produced in low energy nuclear processes. (05 Mar 2000) |
| Addison's clinical planes | A series of plane's used as landmarks in thoracoabdominal topography; the trunk is divided vertically by a median plane from the upper border of the manubrium of the sternum to the pubic symphysis, by a lateral plane drawn vertically on either side through a point half way between the anterior superior iliac spine and the median plane at the interspinal plane, and by an interspinal plane passing vertically through the anterior superior iliac spine on either side; transversely the trunk is divided by a transthoracic plane passing across the thorax 3.2 cm above the lower border of the body of the sternum, by a transpyloric plane midway between the jugular notch of the sternum and the pubic symphysis, corresponding to the disc between the first and second lumbar vertebrae, and by an intertubercular plane passing through the iliac tubercles and cutting usually the fifth lumbar vertebra; the plane's formed on these lines, and also on transverse plane's cutting the upper edge of the manubrium and the upper edge of the pubic symphysis, constitute the clinical plane's of Addison. (05 Mar 2000) |
| pathology, clinical | A subspecialty of pathology which deals with the laboratory analysis of specimens of human blood and other fluids. (12 Dec 1998) |
| pharmacology, clinical | The branch of pharmacology that deals directly with the effectiveness and safety of drugs in humans. (12 Dec 1998) |
| phase I clinical trial | <pharmacology> The earliest stage clinical trial for studying an experimental drug in humans. Phase I trials are generally comparatively small and are used to determine toxicity and maximum dose. They provide an initial evaluation of a drug's safety and pharmacokinetics-how the drug is absorbed, what tissues it reaches and how long it takes to leave the body. Such studies also usually test various doses of the drug (dose-ranging) to obtain an indication of the appropriate dose to use in later studies. The patients in these trials usually have advanced disease and have already received best available chemotherapy, therefore, seeing a repose is significant partially because this means there is a lack of cross-resistance between two anti-cancer drugs. (31 Dec 1997) |